ImmunityBio annual meeting: directors re-elected, equity plan shares increased by 19.9M

ImmunityBio, Inc.

All nine director nominees re-elected, including Patrick Soon-Shiong, with over 556M votes For each.
Amendment to increase authorized shares under 2015 Equity Incentive Plan by 19.9M shares approved (547M For).
Say-on-pay advisory vote approved with 556.7M For votes.
Ratification of Ernst & Young as auditor for FY2024 ratified (606.9M For).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.